Spirovant Sciences, Inc
Spirovant Sciences is developing novel gene therapies for cystic fibrosis and other pulmonary diseases. We are the only company advancing programs with both AAV and lentivirus vectors.
7-day free trial · no credit card
Verified contacts
22
available on Kipplo
LinkedIn employees
15
11 to 50 range
Open roles
—
no listings
Distinct roles
16
indexed titles
Tech stack
4
tools in use
Monthly traffic
78
organic / mo
Sign up free to see all 22 verified contacts at Spirovant Sciences, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
22 contacts with verified email or phone · masked until revealed.
- LF
Lillian Falese
Director · General Business & Management
EmailPhone - MG
Matthew Glatfelter
Senior Director, R & d Operations · Operations
EmailPhone - MW
Matthew Weaver
Senior Director, Process Development · Research & Development
EmailPhone - FF
Francine Fielding
Office Manager · Operations
EmailPhone - NS
Nikhil Sarma
Senior Scientist, Analytical Development · Science
EmailPhone - DW
David Whitwell
Chief Financial Officer · Finance & Accounting
EmailPhone - EP
Eric Pastor
() · Other
EmailPhone - EY
Eric Yuen
Co-founder and Chief Medical Advisor · Other
EmailPhone - MM
Madhu Mahankali
() · Other
EmailPhone
Showing 9 of 22 verified contacts
Top roles at Spirovant Sciences, Inc
16 distinct titles indexed · top 10 shown.
- 2()
- 2controller
- 2office manager
- 2senior director, analytical development
- 2senior director, r & d operations
- 1associate scientist
- 1chief financial officer
- 1co-founder and chief medical advisor
- 1director
- 1it specialist
- +6more titles
Sign up to unlock all 22 contacts at Spirovant Sciences, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 22 verified contacts at Spirovant Sciences, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.